Adicet Bio Inc (ACET)
1.875
-0.22
(-10.71%)
USD |
NASDAQ |
Apr 24, 16:00
1.875
0.00 (0.00%)
After-Hours: 20:00
Adicet Bio Total Assets (Quarterly): 207.30M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 207.30M |
| September 30, 2023 | 233.26M |
| June 30, 2023 | 277.63M |
| March 31, 2023 | 304.97M |
| December 31, 2022 | 330.69M |
| September 30, 2022 | 354.30M |
| June 30, 2022 | 329.90M |
| March 31, 2022 | 340.45M |
| Date | Value |
|---|---|
| December 31, 2021 | 338.94M |
| September 30, 2021 | 257.20M |
| June 30, 2021 | 268.78M |
| March 31, 2021 | 282.07M |
| December 31, 2020 | 153.84M |
| September 30, 2020 | 150.40M |
| December 31, 2019 | 81.59M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
81.59M
Minimum
Dec 2019
354.30M
Maximum
Sep 2022
260.75M
Average
277.63M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Sagimet Biosciences Inc | 96.72M |
| Catalyst Pharmaceuticals Inc | 470.11M |
| Codexis Inc | 136.56M |
| Annexon Inc | 297.67M |
| Inhibrx Inc | 307.89M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.12M |
| Shareholders Equity (Quarterly) | 170.18M |